Ambrisentan: a guide to its use in pulmonary arterial hypertension classified as WHO functional class II or III

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.27, Iss.1, 2011-01, pp. : 1-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ambrisentan: a guide to its use in pulmonary arterial hypertension

By Behr Jürgen

Drugs & Therapy Perspectives, Vol. 25, Iss. 7, 2009-07 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Sitaxentan: a guide to its use in pulmonary arterial hypertension

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 23, Iss. 9, 2007-09 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Sildenafil: A Review of its Use in Pulmonary Arterial Hypertension

By Croom Katherine F. Curran Monique P.

Drugs, Vol. 68, Iss. 3, 2008-01 ,pp. : 383-397

Adis International

Access to resources Recommend Favorite

Bosentan: A Review of its Use in Pulmonary Arterial Hypertension and Systemic Sclerosis

By Oldfield Vicki Lyseng-Williamson Katherine A.

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 189-208

Adis International

Access to resources Recommend Favorite

Bosentan: A Review of its Use in the Management of Mildly Symptomatic Pulmonary Arterial Hypertension

By Dhillon Sohita Keating Gillian M.

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 5, 2009-10 ,pp. : 331-350

Adis International

Access to resources Recommend Favorite